Hepatitis C Virus NS2 Protein Suppresses RNA Interference in Cells

被引:15
|
作者
Zhou, Hui [1 ]
Qian, Qi [1 ,2 ]
Shu, Ting [2 ,3 ]
Xu, Jiuyue [2 ,4 ]
Kong, Jing [2 ,4 ]
Mu, Jingfang [2 ]
Qiu, Yang [2 ,4 ]
Zhou, Xi [1 ,2 ,4 ]
机构
[1] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China
[2] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China
[3] Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan 430040, Hubei, Peoples R China
[4] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatitis C virus (HCV); NS2; Antiviral RNAi; Viral suppressor of RNAi (VSR); IMMUNITY; INHIBITOR; INFLUENZA; ACTS;
D O I
10.1007/s12250-019-00182-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
RNAi interference (RNAi) is an evolutionarily conserved post-transcriptional gene silencing mechanism and has been well recognized as an important antiviral immunity in eukaryotes. Numerous viruses have been shown to encode viral suppressors of RNAi (VSRs) to antagonize antiviral RNAi. Hepatitis C virus (HCV) is a medically important human pathogen that causes acute and chronic hepatitis. In this study, we screened all the nonstructural proteins of HCV and found that HCV NS2 could suppress RNAi induced either by small hairpin RNAs (shRNAs) or small interfering RNAs (siRNAs) in mammalian cells. Moreover, we demonstrated that NS2 could suppress RNAi via its direct interaction with double-stranded RNAs (dsRNAs) and siRNAs, and further identified that the cysteine 184 of NS2 is required for the RNAi suppression activity through a serial of point mutation analyses. Together, our findings uncovered that HCV NS2 can act as a VSR in vitro, thereby providing novel insights into the life cycle and virus-host interactions of HCV.
引用
收藏
页码:436 / 444
页数:9
相关论文
共 50 条
  • [41] Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro
    Weng, Leiyun
    Tian, Xiao
    Gao, Yayi
    Watashi, Koichi
    Shimotohno, Kunitada
    Wakita, Takaji
    Kohara, Michinori
    Toyoda, Tetsuya
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (12): : 1886 - 1892
  • [42] Fluorescence Resonance Energy Transfer-Based Assay for Characterization of Hepatitis C Virus NS3-4A Protease Activity in Live Cells
    Sabariegos, Rosario
    Picazo, Fernando
    Domingo, Beatriz
    Franco, Sandra
    Martinez, Miguel-Angel
    Llopis, Juan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 728 - 734
  • [43] Physical methods to determine the binding mode of putative ligands for hepatitis C virus NS3 helicase
    Sarver, RW
    Rogers, JM
    Stockman, BJ
    Epps, DE
    DeZwaan, J
    Harris, MS
    Baldwin, ET
    ANALYTICAL BIOCHEMISTRY, 2002, 309 (02) : 186 - 195
  • [44] Characterization of the interaction between hepatitis C virus NS5B and the human oestrogen receptor alpha
    Hillung, Julia
    Ruiz-Lopez, Elena
    Bellon-Echeverria, Itxaso
    Clemente-Casares, Pilar
    Mas, Antonio
    JOURNAL OF GENERAL VIROLOGY, 2012, 93 : 780 - 785
  • [45] Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli
    Mori, A
    Yamada, K
    Kimura, J
    Koide, T
    Yuasa, S
    Yamada, E
    Miyamura, T
    FEBS LETTERS, 1996, 378 (01) : 37 - 42
  • [46] Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2
    Asante-Appiah, Ernest
    Ingravallo, Paul
    McMonagle, Patricia
    Bystol, Karin
    Xia, Ellen
    Curry, Stephanie
    Qiu, Ping
    Black, Stuart
    Chase, Robert
    Liu, Rong
    Lahser, Fred
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (12)
  • [47] Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole
    Ishida, T
    Suzuki, T
    Hirashima, S
    Mizutani, K
    Yoshida, A
    Ando, I
    Ikeda, S
    Adachi, T
    Hashimoto, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1859 - 1863
  • [48] New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B
    Rai, Roopa
    Deval, Jerome
    ANTIVIRAL RESEARCH, 2011, 90 (02) : 93 - 101
  • [49] Molecular Mechanism Underlying the Suppression of CPB2 Expression Caused by Persistent Hepatitis C Virus RNA Replication
    Sejima, Hiroe
    Satoh, Shinya
    Dansako, Hiromichi
    Honda, Masao
    Kaneko, Shuichi
    Ikeda, Masanori
    Kato, Nobuyuki
    ACTA MEDICA OKAYAMA, 2016, 70 (02) : 75 - 88
  • [50] Hepatitis C virus alternate reading frame protein decreases interferon-a secretion in peripheral blood mononuclear cells
    Xu, Xiaodong
    Yu, Xiaojie
    Deng, Xiaozhao
    Yue, Ming
    Zhang, Jinhai
    Zhu, Danyan
    Zhou, Zhenxian
    Zhai, Xiangjun
    Xu, Ke
    Zhang, Yun
    MOLECULAR MEDICINE REPORTS, 2014, 9 (02) : 730 - 736